R. Cuppone

440 total citations
17 papers, 301 citations indexed

About

R. Cuppone is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, R. Cuppone has authored 17 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 3 papers in Rheumatology. Recurrent topics in R. Cuppone's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). R. Cuppone is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). R. Cuppone collaborates with scholars based in Italy, United States and France. R. Cuppone's co-authors include Onofrio G. Manghisi, Raffaele Cozzolongo, Emilio Jirillo, L. Caradonna, D. Caccavo, L. Amati, Antonio Amoroso, Giorgio Maria Saracco, F. Rosina and Grazia Anna Niro and has published in prestigious journals such as Gastroenterology, International Journal of Epidemiology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

R. Cuppone

17 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Cuppone Italy 9 199 192 64 26 20 17 301
Pasqualina De Leo Italy 8 150 0.8× 115 0.6× 47 0.7× 10 0.4× 29 1.4× 23 246
Maria Lúcia Alves Pedroso Brazil 11 175 0.9× 135 0.7× 45 0.7× 16 0.6× 37 1.9× 22 296
Ernest Song South Africa 9 240 1.2× 209 1.1× 39 0.6× 26 1.0× 56 2.8× 16 339
R. Zachoval Germany 11 154 0.8× 103 0.5× 23 0.4× 57 2.2× 34 1.7× 28 319
Eleni Gigi Greece 11 212 1.1× 204 1.1× 38 0.6× 30 1.2× 15 0.8× 22 302
Tiziana Tieghi Italy 8 130 0.7× 139 0.7× 18 0.3× 20 0.8× 36 1.8× 14 248
Sergio Scaccabarozzi Italy 6 326 1.6× 334 1.7× 24 0.4× 19 0.7× 44 2.2× 10 419
U. Oesen Germany 6 471 2.4× 497 2.6× 40 0.6× 10 0.4× 27 1.4× 7 533
P Bagros France 8 191 1.0× 104 0.5× 73 1.1× 21 0.8× 38 1.9× 20 342
Susana López Argentina 9 166 0.8× 206 1.1× 25 0.4× 97 3.7× 23 1.1× 15 293

Countries citing papers authored by R. Cuppone

Since Specialization
Citations

This map shows the geographic impact of R. Cuppone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Cuppone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Cuppone more than expected).

Fields of papers citing papers by R. Cuppone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Cuppone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Cuppone. The network helps show where R. Cuppone may publish in the future.

Co-authorship network of co-authors of R. Cuppone

This figure shows the co-authorship network connecting the top 25 collaborators of R. Cuppone. A scholar is included among the top collaborators of R. Cuppone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Cuppone. R. Cuppone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Monno, Rosa, A. Panarese, R. Cuppone, et al.. (2020). Evaluation of Antibiotic Resistance of Helicobacter pylori Strains Isolated in Bari, Southern Italy, in 2017–2018 by Phenotypic and Genotyping Methods. Microbial Drug Resistance. 26(8). 909–917. 11 indexed citations
2.
Mastronardi, Mauro, Elisabetta Cavalcanti, Osvaldo Burattini, et al.. (2019). Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease. Frontiers in Medicine. 6. 234–234. 6 indexed citations
3.
Cuppone, R., et al.. (2019). A case report of esophageal actinomycosis in an immunocompetent patient and review of the literature.. PubMed. 42(1). 55–60. 4 indexed citations
4.
Cozzolongo, Raffaele, R. Cuppone, José Petruzzi, Tommaso Stroffolini, & Onofrio G. Manghisi. (2005). Approach of primary care physicians to hepatitis C: an educational survey from a Southern Italian area. Journal of Infection. 51(5). 396–400. 8 indexed citations
5.
Amati, L., Raffaele Cozzolongo, Onofrio G. Manghisi, et al.. (2004). The Immune Responsiveness in Hepatitis C Virus Infected Patients: Effects of Interferon-Alfa / Ribavirin Combined Treatment on the Lymphocyte Response with Special Reference to B Cells. Current Pharmaceutical Design. 10(17). 2093–2100. 3 indexed citations
6.
Amati, L., L. Caradonna, Thea Magrone, et al.. (2002). Modifications of the Immune Responsiveness in Patients with Hepatitis C Virus Infection following Treatment with IFN-α / Ribavirin. Current Pharmaceutical Design. 8(11). 981–993. 18 indexed citations
7.
Caradonna, L., Mauro Mastronardi, Thea Magrone, et al.. (2002). Biological and Clinical Significance of Endotoxemia in the Course of Hepatitis C Virus Infection. Current Pharmaceutical Design. 8(11). 995–1005. 53 indexed citations
8.
Cozzolongo, Raffaele, R. Cuppone, Vito Giannuzzi, et al.. (2001). Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon. Alimentary Pharmacology & Therapeutics. 15(1). 129–135. 13 indexed citations
9.
Osella, Alberto R., Giovanni Misciagna, Vito Guerra, et al.. (2000). Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. International Journal of Epidemiology. 29(5). 922–927. 33 indexed citations
10.
Rosina, F., P. Conoscitore, R. Cuppone, et al.. (1999). Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology. 117(1). 161–166. 84 indexed citations
11.
Jirillo, Emilio, L. Caradonna, Raffaele Cozzolongo, et al.. (1998). Soluble (s) CD14 and Plasmatic Lipopolysaccharides (LPS) in Patients with Chronic Hepatitis C Before and After Treatment with Interferon (IFN)-α. Immunopharmacology and Immunotoxicology. 20(1). 1–14. 26 indexed citations
12.
Cozzolongo, Raffaele, et al.. (1997). Soluble intercellular adhesion molecule-1 in sera from patients with chronic hepatitis C undergoing interferon treatment. Archives of Virology. 142(3). 567–569. 1 indexed citations
13.
Gréco, Béatrice, et al.. (1996). Immunological Effects Following Administration of Interferon-α in Patients with Chronic Hepatitis C Virus (cHCV) Infection. Immunopharmacology and Immunotoxicology. 18(3). 355–374. 7 indexed citations
14.
Cozzolongo, Raffaele, et al.. (1996). [The risk factors for hepatitis D viral infection in southern Italy].. PubMed. 42(1). 11–6. 1 indexed citations
15.
Jirillo, Emilio, Béatrice Gréco, L. Caradonna, et al.. (1995). Evaluation of Cellular Immune Responses and Soluble Mediators in Patients with Chronic Hepatitis c Virus (CHCV) Infection. Immunopharmacology and Immunotoxicology. 17(2). 347–364. 29 indexed citations
16.
Cuppone, R., Sara Del Vecchio, G. Zanninelli, et al.. (1988). Lymphocyte Function Tests in Cirrhotic Patients under Treatment with Spironolactone and Potassium Canrenoate. Journal of International Medical Research. 16(6). 436–442. 2 indexed citations
17.
Emili, Marco, R. Cuppone, & Giorgio Ricci. (1988). Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.. PubMed. 38(10). 1492–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026